🇺🇸 FDA
Patent

US 11857531

Combination mast cell inhibition for treatment of BPH/LUTS

granted A61KA61K31/352A61K31/495

Quick answer

US patent 11857531 (Combination mast cell inhibition for treatment of BPH/LUTS) held by Northwestern University expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/352, A61K31/495, A61P, A61P13/08